Travelers CFO exercises 25,000 options; holds 26,931.82 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
The Travelers Companies (TRV) EVP & CFO reported an option exercise and share sale. On 11/06/2025, the officer exercised 25,000 stock options at $139.83 per share and sold 25,000 common shares at a weighted average price of $278.2502.
Following these transactions, the officer beneficially owned 26,931.82 shares directly. Derivative holdings included 11,037 stock options remaining. The sales price reflects multiple trades within the $278.25 to $278.252 range.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 25,000 shares ($6,956,255)
Net Sell
3 txns
Insider
Frey Daniel S.
Role
EVP & Chief Financial Officer
Sold
25,000 shs ($6.96M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 25,000 | $0.00 | -- |
| Exercise | Common Stock | 25,000 | $139.83 | $3.50M |
| Sale | Common Stock | 25,000 | $278.2502 | $6.96M |
Holdings After Transaction:
Stock Options (Right to Buy) — 11,037 shares (Direct);
Common Stock — 51,931.82 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did TRV’s CFO report on Form 4?
An exercise of 25,000 stock options at $139.83 and the sale of 25,000 common shares at a weighted average price of $278.2502 on 11/06/2025.
What was the exercise price of the options?
The stock options were exercised at $139.83 per share.
How many derivative securities remain after the transactions?
The officer held 11,037 stock options following the transactions.
What is the officer’s role at The Travelers Companies (TRV)?
The reporting person is the EVP & Chief Financial Officer.
When did the transactions occur?
Both the option exercise and the share sale occurred on 11/06/2025.